Three new organotin( iv ) carboxylate compounds were synthesized and structurally characterized by elemental analysis and FT-IR and multinuclear NMR ( 1 H, 13 C, 119 Sn) spectroscopy. Single X-ray crystallography reveals that compound C2 has a monoclinic crystal system with space group P 2 1 / c having distorted bipyramidal geometry defined by C 3 SnO 2 . The synthesized compounds were screened for drug-DNA interactions via UV-Vis spectroscopy and cyclic voltammetry showing good activity with high binding constants. Theoretical investigations also support the reactivity of the compounds as depicted from natural bond orbital (NBO) analysis using Gaussian 09. Synthesized compounds were initially evaluated on two cancer (HeLa and MCF-7) cell lines and cytotoxicity to normal cells was evaluated using a non-cancerous (BHK-21) cell line. All the compounds were found to be active, with IC 50 values less than that of the standard drug i.e. cisplatin. The cytotoxic effect of the most potent compound C2 was confirmed by LDH cytotoxicity assay and fluorescence imaging after PI staining. Apoptotic features in compound C2 treated cancer cells were visualized after DAPI staining while regulation of apoptosis was observed by reactive oxygen species generation, binding of C2 with DNA, a change in mitochondrial membrane potential and expression of activated caspase-9 and caspase-3 in cancer cells. Results are indicative of activation of the intrinsic pathway of apoptosis in C2 treated cancer cells.
more »
« less
Triorganotin (IV) carboxylates as potential anticancer agents: Their synthesis, physiochemical characterization, and cytotoxic activity against HeLa and MCF‐7 cancer cells
Three triorganotin (IV) cyclopentane carboxylates were synthesized and structurally characterized by in solid state by Fourier‐transform infrared spectroscopy and single crystal diffraction, and in solution by NMR (1H,13C, and119Sn) spectroscopy. The complexes were tested for their anticancer activity against MCF‐7 and HeLa cells along with normal BHK‐21 cells. As revealed by MTT assay, complex2was identified as the most potent derivative with an IC50value of 2.59 and 0.051 μM against HeLa and MCF‐7 cells, respectively. The results were compared with cisplatin as reference drug. Fluorescent microscopic studies using 4′,6‐diamidino‐2‐phenylindole (DAPI) and propidium iodide (PI) staining confirmed the occurrence of apoptosis in HeLa cells treated with the most active complex2. The complex2also triggered the release of lactate dehydrogenase (LDH) in treated HeLa and MCF‐7 cells whereas a luminescence assay displayed a remarkable increase in the activity of caspase‐9 and ‐3. Moreover, flow cytometric results revealed that complex2caused G0/G1 arrest in the treated HeLa cells. The complexes were further screened for DNA binding studies through UV‐vis spectroscopy and cyclic voltammetry. The high activity of complex2was attributed to its higher Lewis acidity as indicated by natural bond orbital (NBO) analysis. Theoretical modelling and molecular docking studies were also conducted to study the reactivity of complexes againstVEGFR 2 Kinase.
more »
« less
- Award ID(s):
- 1809116
- PAR ID:
- 10236759
- Publisher / Repository:
- Wiley Blackwell (John Wiley & Sons)
- Date Published:
- Journal Name:
- Applied Organometallic Chemistry
- Volume:
- 35
- Issue:
- 4
- ISSN:
- 0268-2605
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Abstract A new series of mono‐ and bis‐alkynyl CoIII(TIM) complexes (TIM=2,3,9,10‐tetramethyl‐1,4,8,11‐tetraazacyclotetradeca‐1,3,8,10‐tetraene) is reported herein. Thetrans‐[Co(TIM)(C2R)Cl]+complexes were prepared from the reaction betweentrans‐[Co(TIM)Cl2]PF6and HC2R (R=tri(isopropyl)silyl or TIPS (1), ‐C6H4‐4‐tBu (2), ‐C6H4‐4‐NO2(3 a), andN‐mesityl‐1,8‐naphthalimide or NAPMes(4 a)) in the presence of Et3N. The intermediate complexes of the typetrans‐[Co(TIM)(C2R)(NCMe)](PF6)(OTf),3 band4 b, were obtained by treating3 aand4 a, respectively, with AgOTf in CH3CN. Furthermore, bis‐alkynyltrans‐[Co(TIM)(C2R)2]PF6complexes,3 cand4 c, were generated following a second dehydrohalogenation reaction between3 band4 b, respectively, and the appropriate HC2R in the presence of Et3N. These new complexes have been characterized using X‐ray diffraction (2,3 a,4 a, and4 c), IR,1H NMR, UV/Vis spectroscopy, fluorescent spectroscopy (4 c), and cyclic voltammetry.more » « less
-
Abstract Bis‐porphyrin nanocages (M2BiCage, M = FeCl, Co, Zn) and their host‐guest complexes with C60and C70were used to examine how molecular porosity and interactions with carbon nanomaterials affect the CO2reduction activity of metalloporphyrin electrocatalysts. The cages were found to adsorb on carbon black to provide electrocatalytic inks with excellent accessibilities of the metal sites (≈50%) even at high metal loadings (2500 nmol cm−2), enabling good activity for reducing CO2to CO. A complex of C70bound inside(FeCl)2BiCageachieves high current densities for CO formation at low overpotentials (|jCO| >7 mA cm−2,η= 320 mV; >13.5 mA cm−2,η= 520 mV) with ≥95% Faradaic efficiency (FECO), andCo2BiCageachieves high turnover frequencies (≈1300 h−1,η= 520 mV) with 90% FECO. In general, blocking the pore with C60or C70improves the catalytic performance of(FeCl)2BiCageand has only small effects onCo2BiCage, indicating that the good catalytic properties of the cages cannot be attributed to their internal pores. Neither enhanced electron transfer rates nor metal‐fullerene interactions appear to underlie the ability of C60/C70to improve the performance of(FeCl)2BiCage, in contrast to effects often proposed for other carbon nanosupports.more » « less
-
Abstract Reaction of (P)AuOTf [P=P(t‐Bu)2o‐biphenyl] with indenyl‐ or 3‐methylindenyl lithium led to isolation of gold η1‐indenyl complexes (P)Au(η1‐inden‐1‐yl) (1 a) and (P)Au(η1‐3‐methylinden‐1‐yl) (1 b), respectively, in >65 % yield. Whereas complex1 bis static, complex1 aundergoes facile, degenerate 1,3‐migration of gold about the indenyl ligand (ΔG≠153K=9.1±1.1 kcal/mol). Treatment of complexes1 aand1 bwith (P)AuNTf2led to formation of the corresponding cationic bis(gold) indenyl complexestrans‐[(P)Au]2(η1,η1‐inden‐1,3‐yl) (2 a) andtrans‐[(P)Au]2(η1,η2‐3‐methylinden‐1‐yl) (2 b), respectively, which were characterized spectroscopically and modeled computationally. Despite the absence of aurophilic stabilization in complexes2 aand2 b, the binding affinity of mono(gold) complex1 atoward exogenous (P)Au+exceed that of free indene by ~350‐fold and similarly the binding affinity of1 btoward exogenous (P)Au+exceed that of 3‐methylindene by ~50‐fold. The energy barrier for protodeauration of bis(gold) indenyl complex2 awith HOAc was ≥8 kcal/mol higher than for protodeauration of mono(gold) complex1 a.more » « less
-
Abstract The mitochondrial calcium uniporter (MCU) mediates uptake of calcium ions (Ca2+) into the mitochondria, a process that is vital for maintaining normal cellular function. Inhibitors of the MCU, the most promising of which are dinuclear ruthenium coordination compounds, have found use as both therapeutic agents and tools for studying the importance of this ion channel. In this study, six Co3+cage compounds with sarcophagine‐like ligands were assessed for their abilities to inhibit MCU‐mediated mitochondrial Ca2+uptake. These complexes were synthesized and characterized according to literature procedures and then investigated in cellular systems for their MCU‐inhibitory activities. Among these six compounds, [Co(sen)]3+(3, sen=5‐(4‐amino‐2‐azabutyl)‐5‐methyl‐3,7‐diaza‐1,9‐nonanediamine) was identified to be a potent MCU inhibitor, with IC50values of inhibition of 160 and 180 nM in permeabilized HeLa and HEK293T cells, respectively. Furthermore, the cellular uptake of compound3was determined, revealing moderate accumulation in cells. Most notably,3was demonstrated to operate in intact cells as an MCU inhibitor. Collectively, this work presents the viability of using cobalt coordination complexes as MCU inhibitors, providing a new direction for researchers to investigate.more » « less